Paraoxonase (PON) possesses antiatherogenic potentials, but the distinct functions of PON members in alleviating atherosclerosis are not yet clear. This study aimed to evaluate the protective effects of hPON1 and hPON3 against atherosclerosis, and thereby exploring their synergistic mechanism in atherosclerosis development. We generated the recombinant adenovirus AdPON1 and AdPON3, which were capable of expressing hPON1 and hPON3. After AdPON1 and AdPON3 were injected intravenously into 5-week-old apolipoprotein E knockout mice, abundant hPON1 and hPON3 mRNA expression levels were detected. However, increase in serum lactonase activity was detected only in AdPON1-treated mice. Serum antioxidation and antiinflammation capabilities in AdPON1-treated mice, reflected by malondialdehyde, total antioxidant capability and tumor necrosis factor-a levels, were greatly enhanced, whereas those in AdPON3-treated mice were not significantly affected. Nevertheless, histological analysis revealed that adenovirus-mediated expression of hPON1, hPON3 or both of them reduced atherosclerotic plaque area to a similar extent. Although no synergistic mechanism was detected in reducing arterial lesion size, hPON1 and hPON3 showed synergistic effects on promoting macrophage cholesterol efflux. In conclusion, hPON1 and hPON3 exhibited similar potentials in reducing arterial lesion size, but they exerted antiatherogenic effects in distinct ways.
Introduction
Atherosclerosis is a progressive disease characterized by chronic inflammation and accumulation of lipids and fibrous elements in large arteries. 1, 2 The chronic inflammation is caused partly by hypercholesterolemia and subsequent oxidation of low-density lipoprotein (LDL) in the artery wall. Oxidized LDL stimulates the overlying endothelial cells to produce adhesion molecules, chemotactic proteins and growth factors, resulting in the recruitment and differentiation of monocytes/macrophages to the vessel wall. Rapid uptake of highly oxidized LDL particles by macrophages finally leads to foam-cell formation and initiation of atherogenesis. 2 High-density lipoprotein (HDL) is strongly protective against atherosclerosis by removing excess cholesterol from peripheral tissues and inhibiting lipoprotein oxidation. The antioxidant properties of HDL are due, in part, to serum paraoxonase (PON), an esterase carried on HDL that can degrade certain biologically active oxidized phospholipids. The PON gene family in mammals includes at least three members: PON1, PON2 and PON3. PON1 is best studied as an HDL-associated esterase/lactonase in serum and possess the ability to protect lipoproteins against peroxidation by hydrolyzing specific oxidized cholesteryl esters and oxidized phospholipids. 3 Moreover, PON1 has an active role in scavenging free radicals and their metabolic products, thereby collaborating with other HDL-located enzymes against oxidative stress. 4 As the most recently identified member of PON family, PON3 shares approximately 65% similarity at the amino-acid level with PON1 and shows similar in vitro antioxidative properties as PON1. 5, 6 During the past decade, considerable attention was given on the relationship between PON1 activity and peroxidation-involved diseases, with a special emphasis on atherosclerosis. 3 Human serum PON1 activity was lower in atherosclerotic and hypercholesterolemic patients and inversely related to the risk of cardiovascular diseases. 3, 7 In PON1 knockout mice, atherosclerosis development accelerated, whereas hPON1 transgenic mice showed a decreased lesion size. 8, 9 The atheroprotective effect of PON1 was at least partly due to its antioxidative capability, which was suppressed in atherosclerotic patients. 10 In addition, PON1 could reduce the susceptibility of HDL to oxidation and thus preserved the antiatherogenic effects of HDL by promoting reverse cholesterol transport, 11 inhibiting cholesterol biosynthesis and aggregately impairing macrophage foam cell formation. 7, 12 Although much less was known about PON3, recent studies proved that it also possessed similar antiatherogenic capability. In vivo protective effects of PON1 and PON3 against atherogenesis have been investigated using different mice models. 9, 13, 14 PON1 and PON3 share similar potentials in protecting against atherogenesis, but their expression, protein localization and enzymatic activities are different, suggesting that their physiological functions are far from redundant. [14] [15] [16] Although transgenic expression of PON1 or PON3 offered a great potential for the treatment of atherosclerosis, there have been few studies that compared the effects of PON1 and PON3 on atherosclerosis in the same model. Moreover, despite their distinct physiological functions, it is not yet clear whether they can work in a synergistic or complementary way to protect against atherosclerosis. In this study, we aimed to compare the effects of hPON1 and hPON3 on atherosclerosis and explore the synergistic mechanism between hPON1 and hPON3 in atherosclerosis development. Our study results showed that hPON1 and hPON3 exerted antiatherogenic effects in distinct ways. Although coexpressions of hPON1 and hPON3 showed synergistic mechanism in promoting macrophage cholesterol efflux, no synergistic effect was detected in reducing arterial lesion size.
Results
Adenovirus-mediated expression of hPON1 and hPON3 in ApoE-KO mice Recombinant adenoviruses AdLacZ, AdPON1 and AdPON3, capable of expressing b-galactosidase, hPON1 and hPON3 were prepared as described in 'Material and methods'. After AdPON1 and AdPON3 were injected into apolipoprotein E knockout (ApoE-KO) mice fed atherogenic diet through tail vein, hPON1 and hPON3 mRNA expression levels were detected in livers from AdPON1-and AdPON3-treated mice, but not from phosphate-buffered saline (PBS)-or AdLacZ-treated mice. Correspondingly, both hPON1 and hPON3 mRNA expression levels were detected from mice injected with the mixture of AdPON1 and AdPON3 (Figure 1a ).
Lactonase activity, one of the common features shared by PON1 and PON3, was proposed to be the molecular bases of their antioxidation capabilities. 6, 17 We monitored serum lactonase activity continuously after adenovirus injection ( Figure 1b ). After treated by AdPON1 or the mixture of AdPON1 and AdPON3, serum lactonase activity significantly increased to about 3.7 or 2.8 times higher than that of control group on the 8th day (Po0.01). Afterwards, the lactonase activity slightly decreased, but still maintained a higher level even after 21 days. However, serum lactonase activity in AdPON3-treated mice did not show any obvious increase during 3 weeks after hPON3 gene delivery.
Effects of hPON1 and hPON3 on lipid peroxidation
To evaluate the in vivo effects of hPON1 and hPON3 on atheroma progression, we examined serum lipids level and antioxidant capability 3 weeks after adenovirus injection. There was no significant difference in serum total cholesterol (TC), triglycerides, HDL-cholesterol and LDL-cholesterol levels among AdPON1-, AdPON3and AdLacZ-treated mice ( Table 1) . Malondialdehyde (MDA) is the major oxidation product of peroxidized polyunsaturated fatty acids and related esters, and thus used as an indicator of lipid peroxidation. In AdPON1treated mice and in mice treated with the mixture of AdPON1 and AdPON3, serum MDA concentrations were 8.36±1.64 and 9.86±2.46 nmol ml À1 (n ¼ 10), respectively, which significantly decreased by 44 and 34% as compared with those of control mice injected with PBS (14.87 ± 3.45 nmol ml À1 , n ¼ 10) or AdLacZ (14.51 ± 3.46 nmol ml À1 , n ¼ 10). Total antioxidant capability (T-AOC) usually serves as an indictor of total antioxidant levels including enzymatic and nonenzymatic antioxidants. In AdPON1-treated mice and mice treated with the combination of AdPON1 and AdPON3, serum T-AOC levels were 6.48 ± 1.31 and 7.31 ± 1.82 U ml À1 (n ¼ 10), respectively, which significantly increased approximately 50-60% as compared with those of control mice injected with PBS (4.13±1.01 U ml À1 , n ¼ 10) or AdLacZ (4.39 ± 0.65 U ml À1 , n ¼ 10). However, serum MDA and T-AOC levels in AdPON3-treated mice did not show significant difference from those of control group (Figure 2 ).
Effects of hPON1 and hPON3 on serum proinflammatory cytokines level
In the early stage of atherogenesis, chronic inflammatory responses are triggered and facilitated by oxidized phospholipids, with proinflammatory cytokines as the hPON1 and hPON3 protect against atherosclerosis C Zhang et al index. 18, 19 In this study, serum tumor necrosis factor-a (TNF-a) and interleukin-1b (IL-1b) levels were determined to evaluate the inflammation status 3 weeks after adenovirus inoculation. Serum TNF-a concentration in AdPON1-treated mice significantly decreased to 6.99 ± 0.64 pg ml À1 (n ¼ 10), only about 70% of control group mice treated with PBS (10.24 ± 2.89 pg ml À1 , n ¼ 10) or AdLacZ (10.30±1.82 pg ml À1 , n ¼ 10), indicating that the expression of TNF-a was modestly suppressed after hPON1 gene delivery ( Figure 3 ). The serum TNF-a concentrations in mice treated with AdPON3 (8.53 ± 2.96 pg ml À1 , n ¼ 10) and the mice treated with the mixture of AdPON1 and AdPON3 (7.80 ± 0.55 pg ml À1 , n ¼ 10) were slightly lower than those of control group, but the differences were not significant (P40.05). However, serum IL-1b levels among different group of mice did not show significant difference (data not shown).
Effects of hPON1 and hPON3 on macrophage cholesterol efflux efficiency
Cholesterol efflux is a major process by which macrophages within the vessel wall secrete cholesterol outside cells, and thereby protecting against atherogenesis. 20 To evaluate the effects of hPON1 and hPON3 on macrophage cholesterol efflux, we isolated peritoneal macrophages from ApoE-KO mice fed atherogenic diet 3 weeks after adenovirus inoculation. The percentages of cholesterol efflux in peritoneal macrophages isolated from AdPON1-and AdPON3-treated mice were 30.4±6.1% (n ¼ 10) and 25.9 ± 9.7% (n ¼ 10), respectively, significantly higher than those of control group mice injected with PBS (16.5 ± 5.3%, n ¼ 10) or AdLacZ (15.3 ± 4.1%, n ¼ 10). There was no significant difference in the cholesterol efflux efficiency between macrophages from AdPON1-and AdPON3-treated mice. Nevertheless, it was noticeable that the cholesterol efflux efficiency of macrophage from ApoE-KO mice treated with the mixture of AdPON1 and AdPON3 was 40.4 ± 6.4% (n ¼ 10), which increased by 33 or 56% as compared with that of AdPON1-or AdPON3-treated mice (Figure 4 ), suggesting that hPON1 and hPON3 worked in a synergistic or complementary manner to promote macrophage cholesterol efflux.
The principal molecules involved in efflux of cholesterol from macrophages are adenosine triphosphate (ATP)-binding cassette transporter A1 (ABCA1) and ATP-binding cassette transporter G1 (ABCG1). 21, 22 To Table 1 Characteristics of ApoE-KO mice 3 weeks after adenovirus treatment hPON1 and hPON3 protect against atherosclerosis C Zhang et al investigate the mechanism of hPONs in promoting macrophage cholesterol efflux, we isolated total RNA from peritoneal macrophages after hPONs gene delivery. Reverse transcription (RT)-PCR analysis revealed that hPON1 and hPON3 mRNA expression were detected in mouse peritoneal macrophages after AdPON1 and AdPON3 injection ( Figure 5 ). Quantitative real-time RT-PCR analyses were also performed to determine the expression level of ABCG1, ABCA1 and scavenger receptor CD36 that transport ox-LDL into macrophages. However, the expression level of CD36, ABCA1 or ABCG1 was not significantly affected by hPON1 and hPON3 gene delivery.
Effects of hPON1 and hPON3 on atherosclerotic lesion area
Atheroma plaque areas in ApoE-KO mice fed atherogenic diet were quantified 3 weeks after adenovirus injection. For each mouse, four cross-sections of the aortic sinus were stained with Oil Red O and examined under light microscopy ( Figure 6A ). The average atherosclerotic lesion areas in the aortic root of AdPON1-and AdPON3injected mice were 81.5 ± 15.2 Â 10 3 mm 2 (n ¼ 10) and 89.06 ± 13.3 Â 10 3 mm 2 (n ¼ 10), respectively, which reduced by 32 and 27% as compared with those of control mice treated with PBS (119.3 ± 16.3 Â 10 3 mm 2 , n ¼ 10) or AdLacZ (122.0 ± 15.4 Â 10 3 mm 2 , n ¼ 10). Similarly, atherosclerotic lesion area in the mice treated with the mixture of AdPON1 and AdPON3 was 91.92 ± 11.63 Â 10 3 mm 2 (n ¼ 10), decreasing by 25% as compared with that of controls ( Figure 6B ). However, there was no significant difference in atherosclerotic lesion size among different group of mice treated with AdPON1, AdPON3 and the mixture of both.
Discussion
In this study, AdPON1 or AdPON3 administration in ApoE-KO mice resulted in prolonged expression of Effects of hPON1 and hPON3 on macrophage cholesterol efflux. Thioglycollate-elicited macrophages were harvested from mouse peritoneal cavity and incubated at 3 Â 10 6 cells per plate with 100 mg ml À1 cholesterol for 24 h at 37 1C. After washing, the cells were incubated with native HDL at 37 1C for another 24 h. Cholesterol efflux from the macrophages was then determined as described in 'Materials and methods' section. Results are given as mean ± s.d.; n ¼ 10. *Po0.05 versus phosphate-buffered saline (PBS) and AdLacZ groups; **Po0.01 versus PBS and AdLacZ groups; # Po0.05 versus AdPON1 group; ## Po0.01 versus AdPON3 group.
hPON1 and hPON3 protect against atherosclerosis C Zhang et al hPON1 or hPON3. The serum lactonase activities toward dihydrocoumarin (DHC) in AdPON1-treated mice increased synchronously with hPON1 mRNA production, but no increase in serum lactonase activity was detected in AdPON3-treated mice in spite of abundant hPON3 mRNA expression. After injected with the same titer mixture of AdPON1 and AdPON3, both hPON1 and hPON3 mRNA expression levels were detected in the liver, but serum latonase activity still maintained a similar level as that of AdPON1-treated mice. Because purified hPON1 and hPON3 showed almost equivalent capabilities in hydrolyzing DHC in vitro, 6 different serum latonase activities between AdPON1-and AdPON3treated mice were possibly due to their own translocation and secretion efficiency. More specifically, the N-terminal sequence of hPON3 might be less effective than that of hPON1 in guiding hPON3 secretion into circulation in mice. 23 In human, both PON1 and PON3 are HDL-associated enzymes that are capable of retarding LDL oxidation and therefore potentially antiatherogenic. 24 In mouse, PON1 is synthesized in liver and secreted into circulation where it binds almost exclusively to HDL. 5 According to this study and previous reports, adenovirus-mediated overexpression of hPON1 in mice correlated with decreases in serum MDA level and the titer of autoantibody against MDA-modified LDL, supporting a direct effect of hPON1 on circulating ox-LDL. Moreover, the decrease in serum oxidative stress and circulating ox-LDL was parallel to a decrease of ox-LDL contents in the plaque. 25 However, no human or mouse PON3 were detected in the HDL isolated from hPON3 transgenic mice that exhibited a significant decrease in atherosclerotic lesion formation. 14 Therefore, hPON3 mainly remained cell bound in hPON3-Tg mice and was not present in sufficient quantities in plasma to affect LDL oxidation significantly. How hPON3 functions in vivo in the transgenic mice is still obscure. Draganov 23 hypothesized that HDL was not indeed the place where PON3 exerted its effect physiologically, and its presence in human serum was likely a pathological result rather than a physiological process. In our study, no obvious hPON1 or hPON3 mRNA expression was detected in mouse aorta after AdPON1 or AdPON3 treatment (data not shown). Although the aortic hPON3 mRNA was detected in hPON3-Tg mice in previous study, the expression level was quiet low. 14 Therefore, the aortic expression of hPON3 probably had a minor role in protecting against atherosclerosis. Because abundant expression of hPON3 was detected in liver after AdPON3 treatment, we hypothesized that hPON3 might be involved in inactivation and degradation of oxidized lipids in the liver and, therefore, decreased systemic oxidative stress and inflammation.
Previous studies have revealed that the native lactonase activity of PON was crucial for their physiological functions in oxidation protection and cholesterol efflux. 26, 27 As expected, the correlation between upregulated lactonase activity and reduced oxidative stress, reflected by lower serum MDA concentration and higher serum T-AOC value than those of control, was observed in AdPON1-treated mice. Lower serum lactonase activity in AdPON3-treated mice was also parallel to the higher level of serum lipid peroxidation. Despite the fact that inoculation of AdPON3 in ApoE-KO mice did not show significant effects on serum latonase activity, antioxidation and anti-inflammation capabilities, hPON3 gene delivery significantly promoted macrophage cholesterol efflux and reduced lesion size to a similar extent as hPON1 did. Thus, overexpression of hPON3 in ApoE-KO mice might exert its antiatherogenic function in a different way from that of hPON1.
Inflammation is a major contributor to atherosclerosis development by its multiple effects on arterial wall and lipoprotein metabolism. Proinflammatory cytokines, including interleukins, TNF-a, macrophage migration inhibitory factor, interferon and colony-stimulating factors, are considered to be important in chronic vascular inflammation and responsible for initiation of atherosclerosis. In clinical trial, circulating TNF-a level is associated with increased risk of atherosclerosis. TNF-a could promote atherogenesis by upregulating cytokine expressions in aorta and oxidized-LDL uptake in macrophages. In ApoE-KO mice, TNF-a deficiency prevented atherosclerotic lesions formation. 28, 29 According to our study results, AdPON1 inoculation significantly decreased serum TNF-a level, but serum TNF-a level in AdPON3 was only slightly lower than that of AdLacZ group (P40.05). Conversely, oxidized lipids could induce monocyte/endothelial cell interactions to initiate the inflammatory response. 30 In this study, the decreased serum lipid peroxidation was consequently corresponding to downregulation of serum TNF-a production in AdPON1-treated mice. The functions of IL-1b in atherosclerosis were described controversial, 31, 32 possibly due to the differences of dietary factors, genetic background and even unknown mechanisms of IL-1 singling pathway. In our study, serum IL-1b level did not show any significant change within 3 weeks after hPON1 and hPON3 gene delivery.
Homeostasis of cholesterol is centered on the metabolism of lipoproteins and the formation of cholesterolloaded foam cells that have a key role in the development of atherogenesis. Cholesterol efflux, the first and most important step of reverse cholesterol transport, can remove excess cholesterol from macrophage through both active and passive processes, so modification of these processes may provide new therapeutic approaches to atherosclerosis. 33, 34 Promoting cholesterol efflux from macrophages has already been proven to be another antiatherogenic property of the PONs. 24 In this study, hPON1 or hPON3 gene delivery exhibited similar potentials in enhancing cholesterol efflux efficiency of isolated peritoneal macrophages. Moreover, macrophage cholesterol efflux efficiency in mice treated with the combination of AdPON1 and AdPON3 significantly increased in contrast with that of AdPON1-or AdPON3treated mice. The synergistic effect between hPON1 and hPON3 suggested that they might promote macrophages cholesterol efflux in different phases of the whole process.
Although hPON1 and hPON3 showed significant synergistic mechanism in promoting macrophages cholesterol efflux, no similar synergistic effect on atherosclerotic lesion size was found in our study. One possible reason is that the outcome of macrophages cholesterol efflux is not accompanied by measurable effects on lesion growth. Another possible reason is that in vitro conditions of cholesterol efflux assaying might not completely reflect the in vivo situation with its complex interaction hPON1 and hPON3 protect against atherosclerosis C Zhang et al between various cell types and multiple factors. Finally, lesion formation was limited in our study by the time frame during which ApoE-KO mice developed intermediate or advanced atherosclerotic lesions. According to previous study, 35 adenovirus-mediated hPON1 gene transfer in ApoE-KO mice with preexisting atherosclerosis failed to reduce the plaque size, but did greatly improve oxidative stress and endothelial cell function in arteries.
In conclusion, adenovirus-mediated expression of hPON1 and hPON3 in ApoE-KO mice exerted antiatherogenic effects in different ways, partly due to their different physiological localizations. Although co-expression of hPON1 and hPON3 did not show synergistic mechanism in reducing atherosclerotic lesion size, there were significant synergistic effects between hPON1 and hPON3 about promoting macrophage cholesterol efflux. Gaining insight into the whole picture of PON1 and PON3 about their antiatherogenic potentials may enable us to develop more effective therapies for atherosclerosis in the future.
Materials and methods

Generation of recombinant adenovirus expressing hPON1 and hPON3
Recombinant adenovirus was prepared using Adenovirus Expression Vector Kit (Takara, Shiga, Japan). Briefly, hPON1 and hPON3 cDNA fragments were blunted and inserted into E1-deleted cosmid vector pAxCAwtit under control of the cytomegalovirus promoter to generate pAxCAwtit-hPON1 and pAxCAwtit-hPON3, respectively. Recombinant cosmid pAxCAwtit-LacZ, which contained LacZ gene (encoding b-galactosidase) under the control of the cytomegalovirus promoter, was provided by the manufacturer. After linearized pAxCAwtit-LacZ, pAxCAwtit-hPON1 and pAxCAwtit-hPON3 were transfected into HEK293A cells, recombinant adenovirus AdLacZ, AdPON1 and AdPON3 were screened and propagated according to the instructions given by the manufacturer. After large-scale preparation, AdLacZ, AdPON1 and AdPON3 particles were concentrated by ViraBind Adenovirus Purification Kit (Cell Biolabs, San Diego, CA, USA).
Animals and gene transfer
The animal experiments were conducted in compliance with the Guide for the Care and Use of Laboratory Animals in Jiangsu Province, PR China Male ApoE-KO mice on C57BL/6 background were purchased from the Center of Model Animals, Peking University. For the experiments described, mice were kept on a regular chow initially and on the atherogenic diet (21% fat, 0.15% cholesterol) when they were 4-week old. Adenovirus was injected into mice through tail vein when mice were 5-week old. Before injection, adenovirus was diluted in PBS to produce an inoculum of 1 Â 10 9 infectious units (IU) in 150 ml PBS. Two groups of ApoE-KO mice were injected with 150 ml AdPON1 and AdPON3, respectively. In the third group, ApoE-KO mice were injected with 150 ml adenoviruscontaining mixture with equal amount of AdPON1 and AdPON3. Two control groups of ApoE-KO mice were injected with 150 ml PBS and AdLacZ, respectively. Ten mice were recruited for each experimental group.
Serum lactonase activity assay
Mouse serum lactonase activity was determined using DHC as the substrate as previously described. 36 The E270 for reaction was 1295 M À1 cm À1 . One unit of lactones activity is equal to 1 mmol of DHC hydrolyzed per ml per min.
Reverse transcription-PCR analysis
Total RNA was isolated from 10 mg mouse liver using RNA Isolation & Purification kit (Waston, Shanghai, China). First-strand cDNA was synthesized using SYBR PrimeScript RT-PCR Kit (Takara, Dalian, China). hPON1and hPON3-specific primers were designed to avoid amplified mouse PON1 or PON3 as follows: hPON1forward: CGGCTGATTGCGCTCACCCTCT, reverse: CGT ACAGTTAGGAAGTTCTACG; hPON3-forward: CGGGG AAGCTCGTGGCGCTGGT, reverse: CGGCCTGGATATTT TAATCCAC. Mouse GAPDH was amplified as an internal control (forward: TTAGACCCCTGGCCAAGG, reverse: CTTACTCCTTGGAGGCCATG). The PCR program was the following: denaturation at 94 1C for 3 min, followed by 30 cycles of 30 s at 94 1C, 30 s at 60 1C, 90 s at 72 1C, and a final polymerization step at 72 1C for 7 min.
Serum lipid concentration
Mice were killed to collect blood 3 weeks after adenovirus treatment. Serum TC, HDL-cholesterol, LDL-cholesterol and triglyceride levels were assessed using Hitachi 7020 Automatic Biochemical Analyzer (Hitachi, Tokyo, Japan).
Serum lipid peroxidation and total antioxidative capability
Lipid peroxidation was spectrophotometrically determined by measuring the serum level of malonyldialdehyde (MDA) using MDA Quantitative Analysis Kit (Jiancheng, Nanjing, China). Serum T-AOC, reflecting the ability of total enzymatic and nonenzymatic antioxidants, was determined by T-AOC Analysis Kit (Jiancheng) and expressed as U ml À1 serum.
Serum inflammatory cytokines levels
Serum IL-1b and TNF-a concentrations were determined using enzyme-linked immunosorbent assay kits according to the manufacturer's instructions (eBioscience, San Diego, CA, USA).
Peritoneal macrophage isolation and cholesterol efflux analysis
Peritoneal macrophage isolation and cholesterol efflux assaying were performed as per previously described methods. 37 In brief, 3 days after administration of intraperitoneal injection of 3% Brewer's thioglycollate medium, macrophages were harvested by washing mice peritoneal cavity with sterile saline. The isolated cells were centrifuged and suspended in high-glucose Dulbecco's modified Eagle's medium at a concentration of 1 Â 10 6 per ml. About 3 Â 10 6 macrophage cells were allowed to adhere on a 60 mm plate at 37 1C in the presence of 100 mg ml À1 cholesterol for 24 h. The adhering cells were then washed six times with Dulbecco's modified Eagle's medium containing 1% bovine serum albumin and incubated for another 24 h with 50 mg ml À1 of native HDL. Subsequently, the supernatant was hPON1 and hPON3 protect against atherosclerosis C Zhang et al removed and the cells were washed and lysed by ultrasonication. After total cholesterol in the medium and cell lysate were extracted by chloroform, their concentrations were measured using Cholesterol Microanalysis Kit (Jiancheng). Cellular cholesterol efflux was expressed as the percentage of cholesterol in the medium compared to total cholesterol in medium and cell lysate.
Quantitative real-time RT-PCR analysis of mRNA expression
Total RNA was isolated from mice peritoneal macrophages using RNA Isolation & Purification kit (Waston) according to the manufacturer's instructions. Total RNA (1 mg) from each sample was used to determine the expression of CD36, ABCA1 and ABCG1 at mRNA level by real-time RT-PCR using SYBR PrimeScript RT-PCR Kit (Takara) in an ABI 7500 Fast real-time PCR System (PE Applied Biosystems, Foster City, CA, USA) according to the manufacturer's protocol. The primers used for PCR are as follows-CD36, forward: GCCAAGCTATTGCG ACATGAT and CD36, reverse: GCAAATGTCAGAGGA AAAGAATCTC; ABCA1, forward: TCAACTTTTACG AAGGCCAGATT and ABCA1, reverse: GATGTAGGC CGTGCCAGAAG; ABCG1, forward: TCCTGCTCTTCT CCGGATTCT and ABCG1, reverse: ACCCCCTCAAA GCCGTATCT; b-actin, forward: GACCTCTATGCCAAC ACAGTGC and b-actin, reverse: GTACTCCTGCTTGC TGATCCAC. Individual gene expression was quantified using standard curve and normalized to b-actin mRNA expression. The PCR conditions were as follows: 95 1C for 30 s, and then 40 cycles of amplification for 3 s at 95 1C and 25 s at 60 1C.
Lesion analysis
The heart containing its proximal aorta was embedded in OCT compound. Four 10 mm thick cryosections of aorta sinus from one mouse were cut and stained with Oil Red O and hematoxylin. Aortic lesions were quantified using Image-Pro Plus software (Media Cybernetics, Silver Spring, MD, USA). The mean area of lipid staining from the four sections was determined for each mouse.
Statistical analysis
The data were analyzed for statistical significance using one-way analysis of variance and Student's t-test. Statistical significance was determined at Po0.05.
